195 related articles for article (PubMed ID: 6931871)
1. Gemfibrozil--a new lipid lowering agent.
Nash DT
J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
[TBL] [Abstract][Full Text] [Related]
2. Effect of gemfibrozil on serum lipid levels.
Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
Artery; 1980; 7(3):224-31. PubMed ID: 7008748
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Jamska B; Nowacki G
Przegl Lek; 1987; 44(12):828-36. PubMed ID: 3330252
[No Abstract] [Full Text] [Related]
4. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Iwanejko J; Nowacki G
Przegl Lek; 1987; 44(12):837-43. PubMed ID: 3330253
[No Abstract] [Full Text] [Related]
5. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
6. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
[TBL] [Abstract][Full Text] [Related]
7. Gemfibrozil treatment: a comparison with clofibrate.
Howard AN; Ghosh P
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
[TBL] [Abstract][Full Text] [Related]
8. [Anti-arrhythmic action of penfenon and clofibrate].
Ryzhenkov VE; Miroshkin PM
Patol Fiziol Eksp Ter; 1980; (5):58-61. PubMed ID: 7422376
[No Abstract] [Full Text] [Related]
9. Gemfibrozil for hyperlipidemia.
Med Lett Drugs Ther; 1982 Jun; 24(612):59-60. PubMed ID: 6953310
[No Abstract] [Full Text] [Related]
10. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
Bolzano K; Krempler F; Schellenberg B; Schlierf G
Acta Med Austriaca; 1979; 6(3):90-4. PubMed ID: 547652
[TBL] [Abstract][Full Text] [Related]
11. Effects of gemfibrozil on serum lipids.
Samuel P
Am J Med; 1983 May; 74(5A):23-7. PubMed ID: 6573843
[TBL] [Abstract][Full Text] [Related]
12. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
[No Abstract] [Full Text] [Related]
13. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
Manninen V
Am J Cardiol; 1983 Aug; 52(4):35B-38B. PubMed ID: 6351578
[No Abstract] [Full Text] [Related]
14. [Plafibride treatment of hyperlipidemias type II and IV].
Soler J; Vinzia C; Gómez JM; Morató J
Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212
[No Abstract] [Full Text] [Related]
15. [Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
Altomonte L; Mingrone G; Negrini A; De Cunto F; Greco AV
Clin Ter; 1981 Jan; 96(1):31-8. PubMed ID: 7016409
[No Abstract] [Full Text] [Related]
16. [Long-term therapy of type II and type IV hyperlipoproteinemia using beclobrate].
Uglesić A; Ljachnicky N
Schweiz Rundsch Med Prax; 1988 Jul; 77(27-28):755-61. PubMed ID: 3041534
[No Abstract] [Full Text] [Related]
17. Combination drug therapy for familial combined hyperlipidemia.
East C; Bilheimer DW; Grundy SM
Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
[TBL] [Abstract][Full Text] [Related]
18. Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
Vessby B; Lithell H; Boberg J; Hellsing K; Werner I
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):32-7. PubMed ID: 798194
[TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia: reducing the chances of cardiovascular disease.
Nash DT
Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
[No Abstract] [Full Text] [Related]
20. The evaluation of lipoprotein changes during gemfibrozil treatment.
Janus ED; Costa D; Ononogbu IC; Lewis B
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
